Stemline Therapeutics Inc

Candriam S.C.A.

Report date

3/31/2020

Quarter

2020 Q1

Filed

5/26/2020

Shares

149,466

Value ($000)

1,553

Weight

0.0%

2019 Q3 - 2020 Q1 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q1	5/26/2020	1,553	0.0%	149,466	3/31/2020
2019 Q4	2/5/2020	1,589	0.0%	149,438	12/31/2019
2019 Q3	2/5/2020	1,187	0.0%	114,000	9/30/2019